Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1992 2
1993 1
1994 1
1996 1
1998 3
2000 3
2002 4
2003 4
2004 1
2006 2
2007 3
2008 1
2009 1
2010 1
2011 4
2012 2
2013 3
2014 2
2015 2
2016 3
2017 1
2019 1
2021 2
2022 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age.
Maggiolo F, Rizzardini G, Molina JM, Pulido F, De Wit S, Vandekerckhove L, Berenguer J, D'Antoni ML, Blair C, Chuck SK, Piontkowsky D, Martin H, Haubrich R, McNicholl IR, Gallant J. Maggiolo F, et al. Among authors: chuck sk. HIV Med. 2023 Jan;24(1):27-36. doi: 10.1111/hiv.13319. Epub 2022 May 8. HIV Med. 2023. PMID: 35527425 Free PMC article. Clinical Trial.
Levofloxacin and sparfloxacin: new quinolone antibiotics.
Martin SJ, Meyer JM, Chuck SK, Jung R, Messick CR, Pendland SL. Martin SJ, et al. Among authors: chuck sk. Ann Pharmacother. 1998 Mar;32(3):320-36. doi: 10.1345/aph.17178. Ann Pharmacother. 1998. PMID: 9533064 Review.
Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial.
Maggiolo F, Rizzardini G, Molina JM, Pulido F, De Wit S, Vandekerckhove L, Berenguer J, D'Antoni ML, Blair C, Chuck SK, Piontkowsky D, Martin H, Haubrich R, McNicholl IR, Gallant J. Maggiolo F, et al. Among authors: chuck sk. Infect Dis Ther. 2021 Jun;10(2):775-788. doi: 10.1007/s40121-021-00419-5. Epub 2021 Mar 9. Infect Dis Ther. 2021. PMID: 33686573 Free PMC article.
Collaborative drug therapy management by pharmacists--2003.
Hammond RW, Schwartz AH, Campbell MJ, Remington TL, Chuck S, Blair MM, Vassey AM, Rospond RM, Herner SJ, Webb CE; American College of Clinical Pharmacy. Hammond RW, et al. Among authors: chuck s. Pharmacotherapy. 2003 Sep;23(9):1210-25. doi: 10.1592/phco.23.10.1210.32752. Pharmacotherapy. 2003. PMID: 14524655
48 results